Decatropis bicolor (Zucc.) Radlk essential oil induces apoptosis of the MDA-MB-231 breast cancer cell line by C. C. Estanislao Gómez et al.
RESEARCH ARTICLE Open Access
Decatropis bicolor (Zucc.) Radlk essential oil
induces apoptosis of the MDA-MB-231
breast cancer cell line
C. C. Estanislao Gómez1, A. Aquino Carreño1,2, D. G. Pérez Ishiwara1,3, E. San Martín Martínez4, J. Morales López1,
N. Pérez Hernández1 and M. C. Gómez García1*
Abstract
Background: Decatropis bicolor (Zucc.)Radlk is a plant that has been traditionally used for the treatment of breast
cancer in some communities of Mexico. So, the aim of this study was to determine the cytotoxic and apoptotic
effect of the essential oil of Decatropis bicolor against breast cancer cell line, MDA-MB-231.
Methods: The essential oil obtained from hydrodestillation of leaves of Decatropis bicolor was studied for its biological
activity against breast cancer cells MDA-MB-231 by MTT assay, Hematoxylin-eosin stain, Annexin V-FITC, TUNEL and
western blot assays and for its chemical composition by GC-MS.
Results: The results showed a relevant cytotoxic effect of the essential oil towards MDA-MB-231 cells in a dose- and
time- dependent manner, with an IC50 of 53.81 ± 1.691 μg/ml but not in the epithelial mammary cell line MCF10A
(207.51 ± 3.26 μg/ml). Morphological examination displayed apoptotic characteristics in the treated cells like cell size
reduction, membrane blebbing and apoptotic bodies. In addition, the apoptotic rate significantly increased as well
as DNA fragmentation and western blot analysis revealed that the essential oil induced apoptosis in the MDA-MB-231
cells via intrinsic pathways due to the activation of Bax, caspases 9 and 3. Phytochemical analysis of the Decatropis
bicolor essential oil showed the presence of twenty-three compounds. Major components of the oil were
1,5-cyclooctadiene,3-(methyl-2)propenyl (18.38 %), β-terpineol (8.16 %) and 1-(3-methyl-cyclopent-2-enyl)-cyclohexene
(6.12 %).
Conclusions: This study suggests that essential oil of Decatropis bicolor has a potential cytotoxic and antitumoral effect
against breast cancer cells, with the presence of potential bioactive compounds. Our results contribute to the validation
of the anticancer activity of the plant in Mexican traditional medicine.
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Background
Cancer is a leading cause of mortality worldwide, and
according to the American Cancer Society, deaths
from cancer constitute 2–3 % of the annual deaths
recorded worldwide. An estimated 14.1 million new
cancer cases occurred in 2012, and breast cancer was
the most common cancer diagnosed in women, repre-
senting 25.2 % of all new cases in women [1].
Chemotherapy is a major treatment modality that is
used for the control of breast cancer; however, the
drugs used exhibit severe toxicity to normal tissues,
causing serious side effects [2]. Therefore, many
cancer patients seek alternative and/or complementary
methods of treatment, such as medicinal plants [3],
and there is an urgent need for novel treatment
options with improved properties.
Plants are a potential source for drug discovery and
the development of cancer chemoprevention. In fact, at
least 60 % of the currently used anticancer agents, such
as paclitaxel or the vinca alkaloids, vincristine and
vinblastine, are derived from natural sources [4]. Several
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reports indicate that the anticancer activity of medicinal
plants is due to the presence of different metabolites.
Medicinal plants possess no toxicity compared to modern
(allopathic) drugs [4, 5]. The study of new natural prod-
ucts with anticancer activity is important to synthesize
new chemical derivatives based on bioactivity and the
mechanism of action [5]. Additionally, the essential oils
obtained from natural sources have become increasingly
popular as naturally occurring bioactive agents [6].
Essential oils (EOs) are volatile complex compounds
characterized by a strong odor that are formed by aromatic
plants as secondary metabolites. They have been widely
used for bactericidal, insecticidal, fungicidal, antioxidant,
anticancer, cardiovascular, cosmetic and food applications
[7, 8]. EOs obtained from medicinal plants have biological
effects via the induction of apoptosis in various cancer cell
lines and are promising for the development of novel anti-
cancer agents.
Rutaceae is a plant family which comprises about 161
genera and 1813 species distributed worldwide [9]. Some
plants of this family have been widely used in traditional
medicine and in the cosmetic, food and pharmaceutical
industries, where both, the extracts and the EOs have been
proven [10–12]. In particularly, Mexico has a traditional
of using medicinal plants from Rutaceae family such as
Decatropis bicolor (Zucc.)Radlk. This plant is commonly
known as arantho, is a 2–3-m tall shrub with small white
flowers that is distributed from Mexico to Centroamerica.
Several studies demonstrated antifungal [13] and anti-
inflammatory activities of different extracts of this plant
[14]. The aerial parts of D. bicolor are traditionally used
for ailments, such as backache, headache, flu, some injur-
ies, and cancer. In communities such as El Cardonal, in
Hidalgo State, Mexico, the leaves of D. bicolor are used to
prepare infusions with approximately 5 g of aerial parts
per 1 lt of water, boiled for 15 min and drunk as daily
water for the treatment of breast cancer [15–18]; there-
fore, evaluating the effects of the extracts and the EO of
this plant is important to determine its antitumoral activ-
ity. Moreover, the plant is used to treat certain inflamma-
tory and oxidative diseases and may have anticancer
effects because there is a relationship between the produc-
tion of reactive oxygen species and the origin of oxidation
and inflammation that can lead to cancer.
The objective of the present study was to assess the
cytotoxic activity of different plant extracts and the EO of
arantho in the metastatic breast cancer cell line, MDA-
MB-231, to determine their specific anticancer activities
using various assays.
Methods
Plant material and extraction
The plant was collected in El Cardonal, Hidalgo State,
Mexico on April, 2013. Taxonomic identification of the
plant was performed by a botanist at the herbarium Izta of
the FES-Iztacala, UNAM (Universidad Nacional Autonoma
de Mexico), and a voucher specimen (1917) was deposited
in the herbarium.
To prepare the different extracts, maceration technique
was used, the leaves were washed and dried at room
temperature and then ground into a powder. Four different
solvents, water, ethanol, acetone, and hexane, were used.
For each extraction, 10 g of the plant was dissolved in
100 mL of the different solvents and left it to macerate in
the dark for 24 h. Then, each extract was filtered and either
lyophilized (water) or vacuum-evaporated (ethanol, acet-
one, hexane). For EO isolation, fresh leaves (1 kg) were
chopped and hydrodistilled separately for 4 h using a low
pressure and low temperature method reported previously
[19]. Leaves were ground with water in a blender, deposited
into a flask and then brought to a boil. The vapors were
condensed on a cold surface using a condenser. The EO
was separated based on the difference in density and
immiscibility, which was then collected and stored at 4 ° C
until use. Each extract and the EO were dissolved in 0.1 %
dimethylsulfoxide (DMSO) and then diluted with DMEM
to the desired final concentration.
EO analysis by the gas chromatography–mass spectrometry
(GC-MS) method
EO was diluted in dichloromethane at a ratio of 2:48. A
volume of 1 μL was manually injected in the split mode
into a GC–MS (Perkin Elmer, Turbo Mass Autosystem XL,
(Norwalk, CT)) equipped with an HP-FFAP capillary col-
umn 19091 F-413 (30 m*0.32 id*0.25 μm film thickness).
The injection port was at 180 °C, and the oven temperature
was set at 50 °C, increased to 130 °C at a rate of 6 °C min−1
and maintained for 3 min. A second set was used at 200 °C,
with an increase of 8 °C min−1 over 8 min. The carrier gas
was high-purity helium at 8 psi. The selective mass detector
was a quadrupole Perkin Elmer TurboMass with an elec-
tronic impact ionization system at 70 eV and at 215 °C. The
results are presented as the relative area % of the total-ion
chromatogram, and the percentage composition was calcu-
lated by the normalization method of peak areas from the
GC as the average value of three injections of oil without
correction factors. The compounds were identified by com-
paring the spectra of the compounds from the EO with the
spectral database (NIST MS Search 1.7). The linear reten-
tion indices (RI) of the volatile compounds were calculated
with n-alkanes series (C10-C26).
Cell culture
The breast adenocarcinoma MDA-MB-231 and the epithe-
lial mammary cell line MCF10-A were purchased from
American Type Culture Collection (ATCC, Rockville).
MDA-MB-231 cell line was maintained in DMEM (Dulbec-
co’s Modified Eagle Medium, Gibco) supplemented with
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5 % fetal bovine serum (Invitrogen). MCF10-A cell line was
maintained in DMEM/F12 medium supplemented with
10 % serum fetal bovine, hydrocortisone (1 mg/mL), EGF
(100 mg/mL) and insulin (100 mg/mL). The cells were
grown at 37 °C in a humidified atmosphere of 5 % CO2.
MTT viability assay
Cell viability was evaluated by a MTT (3-(4, 5- dimethyl
thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay using
a modified method of Mosmann [20]. Briefly, 7000 cells
were seeded in 96 microplates and incubated for 24 h at
37 °C in 5 % CO2. Next, the medium was removed and
replaced with fresh medium with or without treatment.
The cells were treated using different concentrations of
each extract (50–400 μg/mL) and the EO (20–100 μg/mL)
and were incubated for 24, 48 and 72 h. Paclitaxel (0.25 μg/
mL) was used as the positive control, and cells with
medium alone and 0.1 % DMSO were used as negative
controls. After incubation, 20 μl of MTT solution (5 mg/
mL) was added to each well and incubated for 3 h. Then,
the medium containing MTT was replaced with 100 μl of
DMSO and the absorbance was measured at 570 nm with
an ELISA reader (Labsystem Multiskan Ms). Each experi-
ment was performed in triplicate and repeated three times.
Cell viability was expressed as the percentage of control
cells. The IC50 (50 % inhibitory concentration) was calcu-
lated using GraphPad Prism 5.0 software.
Cell morphology analysis
EO exhibited the greatest cytotoxic effect on MDA-MB-
231 breast cancer cells; therefore, the following assays
were performed to analyze the apoptotic effect of the EO
on this cell line. To analyze the morphological changes in
the cells caused by EO, the cells were stained with
hematoxylin and eosin (H&E) technique. MDA-MB-231
cells (1x104) were seeded on a 6-well plate for 24 h. After
incubation and attachment, the cells were treated with EO
using the IC50 concentration (53.81 ± 1.691 μg/mL) for 3,
6, 12 and 24 h. Then, the cells were washed with PBS
pH 7.4 and fixed in a 4 % paraformaldehyde solution for
30 min. The cells were washed again and stained with
H&E methods and observed under a light microscope
(Nikon Eclipse TE300).
Annexin V-FITC binding assay
Apoptosis was determined using the Annexin V-FITC
Apoptosis Detection kit (Biovision) according to the
manufacturer’s instructions. Briefly, MDA-MB-231 cells
were cultured at a density of 5x105 and allowed to attach
overnight, followed by treatment with the EO (IC50 value)
or the controls for 0.5, 1.5, 3, 6, 12 and 24 h. The cells were
then harvested by trypsinization, centrifuged and washed
with PBS and incubated in binding buffer with 5 μl of
annexin-V and 5 μl of propidium iodide for 5 min in the
dark at room temperature.
Analysis was performed by flow cytometry (FACScan,
Becton Dickinson Cytometer). A minimum of 10,000 events
was collected for analysis.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL)
DNA fragmentation, a characteristic of apoptosis, was
assessed using an In Situ Cell Death Detection Kit AP
(Roche) following the manufacturer’s instructions. Briefly,
breast cancer cells (5x104) were cultured on 6-well plates
over coverslips and incubated for 24 h. The cells were
then treated with EO (IC50 value) for different times (1.5,
3, 6, 12 and 24 h). Also cells were treated with media
alone, DNAse (3000 U/mL) or paclitaxel (0.25 μg/mL) for
24 h. Next, the cells were washed with PBS and fixed in
paraformaldehyde solution. The cells were incubated in a
permeabilization solution (0.1 % Triton X-100 in 0.1 %
sodium citrate) for 1 h at 4 ° C and then, the cells were
treated with solution A and B for 1 h in the dark at 37 ° C.
Analysis was performed by fluorescence microscopy
(Nikon diaphot 200) with a laser scanning confocal im-
aging system (MCRR 1024).
Western blotting analysis
The analysis of protein expression involved in the two
main pathways of apoptosis was performed by western
blot. MDA-MB-231 breast cancer cells were seeded (5 x
105) for 24 h, and the cells were then treated with EO
(IC50 value) or controls for 0.5, 1.5, 3, 6, 12 and 24 h.
The cells were harvested by trypsinization and washed
with PBS, and the pellet was resuspended in 20 μl of a
protease inhibitor cocktail solution and 100 μl of cold
lysis buffer (50 mM Tris–HCl, 150 mM NaCl, 0.1 %
SDS, 1 % NP-40, 1 mmol phenylmethylsulfonyl fluoride,
100 μM leupeptin, and 2 μg/L aprotinin). The protein ly-
sates were centrifuged at 10, 000 rpm for 10 min at 4 °C.
The protein concentration was determined by Bradford
assay. Protein extracts were reconstituted in sample buffer
and the mixture was boiled for 5 min. Equal amounts
(30 μg) of the denatured proteins were loaded into each
lane and separated on a 15 % SDS polyacrylamide gel,
followed by the transfer of the proteins to a 0.45-μm nitro-
cellulose membranes for 2 h. The membranes were
blocked with 5 % non-fat dry milk and then incubated
with primary rabbit polyclonal antibodies to procaspase-3
(1:200, Santa Cruz, CA), procaspase-8 (1:200, Santa Cruz,
CA), procaspase-9 (1:200, Santa Cruz, CA), Bax (1:200,
Santa Cruz, CA), Bcl-2 (1:200, Santa Cruz, CA), PCNA
(1:100, Santa Cruz, CA), or β-actin (1:1000, Santa Cruz,
CA) as a positive control for 2 h at 4 ° C. They were then
incubated with horseradish peroxidase-conjugated goat
anti-rabbit or anti-mouse secondary antibody (1:2000) for
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2 h before being visualized with diaminobenzidine solu-
tion. All experiments were performed in triplicate.
Statistical analysis
All data are expressed as means ± S.E. One-way ANOVA
followed by Tukey test was used to compare all groups to
each other. For all tests, p < 0.05 was considered significant.
Results
Effect of the different extracts and EO of arantho on viability
The cytotoxic activities of the extracts and EO from ara-
ntho were analyzed by MTT assays performed on the
MDA-MB-231 breast cancer cell line. The aqueous extract
did not show any cytotoxic activity at any concentration
or treatment period against these cancer cells. However,
the ethanolic, acetonic and hexanic extracts showed a
cytotoxic effect in a time- and concentration-dependent
manner, with IC50 values of 128.20 ± 2.035, 203.2 ± 2.3
and 450.7 ± 2.657 μg/mL, respectively (Additional file 1).
As shown in Fig. 1a, a better cytotoxic effect was observed
when the MDA-MB-231 cells were exposed to the EO.
After 24 h of incubation, the cell viability decreased 15,
36, 60 and 77 % with 40, 60, 80 and 100 μg/mL, respect-
ively. In addition, after 48 h of treatment, the cell viability
decreased 35, 69, 88 and 91 % using doses of 40, 60, 80
and 100 μg/mL, respectively. A greater cytotoxic effect
was observed after 72 h of incubation, with a reduction of
cell viability of more than 85 % for 60, 80 and 100 μg/mL.
The cytotoxic effect of the EO was dose- and time-
dependent, with an IC50 of 53.81 ± 1.691 μg/mL. Paclitaxel
(0.25 μg/mL) was used as a positive control and also
caused a decrease in viability of 30, 40 and 53 % at 24, 48
and 72 h, respectively, whereas MDA-MB-231 cells with-
out treatment maintained a viability of 100 %. These re-
sults demonstrate an important and significant cytotoxic
effect of the arantho EO against MDA-MB-231 cells.
To analyze the specificity of the EO against breast can-
cer cells, an epithelial breast cell line, MCF-10A, was
used. The results showed that MCF-10A cells treated
with 20 to 80 μg/mL EO maintained cell viability similar
to the negative controls (100 %) during all treatments.
Higher doses (100 μg/mL) given to the normal epithelial
cells for 72 h decreased the cell viability 25 % (Fig. 1a).
The IC50 value for normal epithelial cells was 207.51 ±
3.26 μg/mL, representing a 2.84-fold higher concentra-
tion compared to the IC50 concentration for breast can-
cer cells. These results confirmed that EO was selective
against breast cancer cells.
Morphological changes on MDA-MB-231 cells exposed to
arantho EO
To determine whether the reduced cell viability of the
cancer cells resulted from cell death induction, MDA-MB-
231 cells were incubated with the EO using the IC50 value
for different times and were stained with H&E. Non-treated
cells possessed an elongated shape; a centrally located
nucleus, forming a confluent colony; and were completely
attached to the plate (Fig. 1b, c). By contrast, cells exposed
to EO showed relevant morphological changes after 3 h of
incubation, including cell size reduction, membrane bleb-
bing, cell shrinkage and loss of colony formation (Fig. 1e).
These changes increased with time, and after 6, 12 and
24 h of incubation, the cells appeared to be rounded and
apoptotic bodies were present (Fig. 1f-h). Similar character-
istics were observed in breast cancer cells exposed to pacli-
taxel (Fig. 1d). These morphological characteristics suggest
the induction of apoptosis by arantho EO.
Apoptotic induction by the arantho EO
To determine and quantify cell death, MDA-MB-231 cells
were incubated with EO (53.81 μg/mL) and analyzed by
Annexin V-FITC assays. Control cells without treatment
showed 98 % non-apoptotic live cells (Fig. 2a, h) and a very
low percent (1–2 %) of apoptosis and necrosis. By contrast,
cells incubated with 0.25 μg/mL paclitaxel showed only
18 % non-apoptotic live cells and displayed 69 and 12 %
apoptotic and necrotic cells, respectively (Fig. 2b, h). Cancer
cells exposed to 53.81 μg/mL of EO showed decreased
non-apoptotic live cells (from 45 to 5 % after 1.5 and 24 h,
respectively) and increased apoptotic cells (from 47 to 85 %
after 1.5 and 24 h, respectively) in a time-dependent man-
ner (Fig. 2c-h). The percent of necrotic cells was similar for
the different treatments. These results indicate that EO in-
duces apoptosis rather than necrosis in MDA-MB-231
breast cancer cells, and this is consistent with the morpho-
logical changes observed by H&E staining.
Arantho EO induced DNA fragmentation in MDA-MB-231
cells
To determine the ability of the arantho EO to trigger DNA
fragmentation as a feature of apoptosis, TUNEL assays
were performed. Breast cancer cells treated with EO
(53.81 μg/mL) showed an increased in DNA fragmentation
after 1.5, 3, 6, 12 and 24 h of incubation (Fig. 3d, e, f, g and
h, respectively). As expected, cancer cells exposed to pacli-
taxel and DNase were also positively stained in the assay
(Fig. 3b and c, respectively). As a control, cancer cells with-
out treatment did not exhibit fluorescence staining in the
nucleus (Fig. 3a). These findings indicate that arantho EO
induced cell death in MDA-MB-231 cells by apoptosis
rather than necrosis.
Apoptotic effect of arantho EO on MDA-MB-231 cells is
mediated by activation of caspase cascades
To analyze the activation of an apoptotic pathway,
western blot assays were performed to evaluate the
expression of proteins, such as PCNA (proliferating cell
nuclear antigen); procaspases 3, 8 and 9; Bcl-2; Bax;
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and β-actin. As shown in Fig. 4a and b, the expression
of the PCNA protein decreased by 35 % after 30 min of
incubation with EO. In addition, at 12 and 24 h, expres-
sion was not detected compared to the untreated cells. By
contrast, the expression of procaspase-8 (55 kDa protein
inactive form) was constant for the different treatments,
suggesting that the extrinsic pathway was not activated.
However, some changes were observed in the expression
of procaspase-9 and 3, corresponding to the inactive form
of the protein for each. The expression of procaspase-9
decreased from 30 to 90 % after 1.5 to 24 h of incubation.
The expression of procaspase-3 decreased by 30 % at 1.5 h
of incubation, but at 24 h, the protein was not detected.
Bcl-2 is an anti-apoptotic protein. It decreased after 12 and
24 h (18 and 40 %, respectively) of incubation with the
breast cancer cells exposed to EO. Bax, a proapoptotic
protein, increased markedly after 3 h of incubation (25 %).
β-actin was used as the loading control and showed equal
Fig. 1 Effect of arantho EO on the cellular viability and on morphological changes a Cell viability was evaluated by MTT assays using different
concentrations and times of incubation (24, 48 and 72 h) of EO on MDA-MB-231, a breast carcinoma cell line, and MCF-10A, an epithelial breast
cell line. b Morphological analysis of MDA-MB-231 breast cancer cells without treatment. c Cells incubated with 0.2 % DMSO. d Cells exposed to
paclitaxel (0.25 μg/mL). e-h Cells incubated with EO (53.81 μg/mL) for 3, 6, 12 and 24 h, respectively. H&E staining, 40x
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intensity bands in all samples. These results indicated that
EO induced apoptotic cell death via activation of the intrin-
sic pathway.
Chemical composition of Arantho EO
EO was obtained using the hydrodistillation method
from the fresh leaves of arantho with a yield of 23 %.
GC-MS analyses were then used to determine the
composition of the extract. Twenty-three compounds,
representing 76.56 % of the EO, were identified (Table 1).
These components were separated into seven classes,
hydrocarbons (24.50 %), terpenes (17.85 %), alcohols
(17.75 %), carboxylic acids (12.33 %), aldehydes (3.04 %),
benzene derivatives (1.07 %) and others (23.46 %). The
major components of the oil were 1,5-cyclooctadiene,3-
(methyl-2) propenyl (18.38 %), β-terpineol (8.16 %), 1-
(3-methyl-cyclopent-2-enyl)-cyclohexene (6.12 %), 2-
heptanol acetate (5.13 %), and limonene (4.49 %). All
other components were present at less than 4 % abun-
dance (Table 1).
Fig. 2 Apoptotic induction of the arantho EO on MDA-MB-231 breast cancer cells analyzed by Annexin V-FITC assays. The results were analyzed
by flow cytometry. Cancer cells with a no treatment; b treatment with 0.25 μg/mL paclitaxel; and c-g treatment with EO (53.81 μg/mL) for 1.5, 3,
6, 12 and 24 h, respectively. h Percent of live, apoptotic and necrotic breast cancer cells with the different treatments. Graphs represent the
average percentages of apoptosis of three independent experiments
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Discussion
D. bicolor is a widely used plant by the people of several
communities of central Mexico for treating breast cancer.
However, little is known regarding its anti-proliferative
effects in this disease. Therefore, the purpose of this study
was to determine whether D. bicolor, commonly known as
arantho, has a cytotoxic effect against breast cancer cells.
In the present study, we obtained different extracts, as
well as the EO of this plant, to investigate its anti-
proliferative effect and to characterize the type of cell
death induced.
Several studies indicate that EOs possess chemo-
preventive potential, anti-tumoral activity and it function
to induce apoptosis in different cancer cell lines [12, 21].
In particularly, plants of the Rutaceae family are charac-
terized by the presence of odoriferous glands containing
aromatic essences, and their EOs are cytotoxic in differ-
ent models of cancer. These plants include Citrus sp.
[11, 22] Zanthopylum fagara [23] and Ruta graveolens
[24]. Several metabolites are representative of this family;
however, the different phytochemical profiles are import-
ant for their biological activity.
In the present study, we showed that arantho EO,
which belongs to the Rutaceae family, had time- and
concentration-selective cytotoxic activity against MDA-
MB-231, a highly invasive estrogen receptor-negative
breast cancer cell line, with an IC50 value of 53.81 μg/
mL, and possessed better effects than the different ex-
tracts of D. bicolor, while no effect was observed using
aqueous extract. The type of compounds extracted from
the plant depends on the polarity, acidity and alkalinity
of the solvent; which means that polar solvents such as
water tends to extract polar compounds (alcohols, amines,
acids, esters, sugars, glycosides), while low- or non-polar
solvents such as the ethanolic, acetonic, hexanic or EO
tends to extract different kinds or different quantities of
non-polar compounds (fats, waxes, volatile oils) [25]. It is
also possible that concentrations of active constituents in
the extracts and in the EO may vary depending on the
extraction conditions; the extraction time; the temperature
or the extraction method. Thus, results suggest that differ-
ential content and/or concentrations specially of polar
compounds, extracted with each extract influenced in the
cytotoxicity observed [26].
On the other hand, the cytotoxicity was not observed in
the MCF-10A epithelial mammary cell line when low con-
centrations of EO were used. The differential EO effect
between these cell lines may be due to the specific genetic
profile; to the membrane potential derived from specific
ion channels; to the distinct adhesion molecules in the
surface, or to other characteristics of breast cancer cells
making it more sensitive to EO [27].
To determine whether the cytotoxic activity of EO was
due to apoptosis, MDA-MB-231 cells were treated for 0 –
24 h with the IC50 value of arantho and analyzed by H&E
staining and TUNEL assays. Apoptosis is programmed cell
death that maintains cellular homeostasis between cell div-
ision and cell death [28]. This physiological process induces
cellular self-destruction, generating diverse morphological
and biochemical features in the nucleus and cytoplasm.
Apoptosis is a primary death induced by natural and cer-
tain synthetic compounds with antitumoral activities [28,
Fig. 3 Analysis of DNA fragmentation by TUNEL assay in MDA-MB-231 breast cancer cells incubated with arantho EO. a Cells without treatment.
b Cells exposed to 0.25 μg/mL paclitaxel. c Cells treated with DNAse (3000 U/mL). d-h Cells incubated with 53.81 μg/mL of EO for 1.5, 3, 6, 12
and 24 h, respectively
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29]. Interestingly, arantho EO induced early (3 h) cell de-
tachment, floating cell size reduction, membrane blebbing,
and cell shrinkage. However, it also induced apoptotic
body formation and chromatin condensation, all of
which are typical features of apoptosis [29]. Moreover,
DNA fragmentation was observed earlier than 3 h
(1.5 h) of exposure to EO, and increased in a time-
dependent manner to 24 h, indicating that the com-
pound or compounds induce cell damage almost imme-
diately, rather than the metabolites. This was confirmed
when we performed a quantitative analysis of apoptosis
using Annexin V-FITC because the results revealed that
47 % of the MDA-MB-231 cells exposed to EO for
1.5 h are in apoptosis, and at 24 h, the apoptosis rate
was 85 %. Furthermore, necrosis was no greater than
18 % in all of the tested conditions. Taken together,
these findings indicate that the EO of D. bicolor in-
duced cell death in MDA-MB-231 cells due to apop-
totic rather than necrotic effects. This is consistent
with the goal of potential anticancer drugs, in which a
primary characteristic is to induce apoptosis. Different
studies using EOs of medicinal plants have demon-
strated their potential anti-cancer activity by inducing
apoptosis or cell cycle arrest [30].
Fig. 4 Western blot analysis of MDA-MB-231 breast cancer cells incubated with arantho EO (53.81 μg/mL) for 0.5, 1.5, 3, 6, 12 and 24 h. a Analysis of the
expression of PCNA; procaspase-3, 8 and 9; Bcl-2; and Bax. The membranes were also detected with an antibody against β-actin as a loading control.
b Relative densitometry of each protein
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Apoptosis is activated by two different pathways, the
intrinsic and extrinsic pathways. The extrinsic pathway is
mediated by death receptors, whereas the intrinsic or
mitochondrial pathway is triggered by the release of apop-
togenic proteins, such as cytochrome c, which activate
caspase proteins that are the main effector molecules that
induce this process [28]. Arantho EO activated caspases 9
and 3 at short treatment times. Caspase 3 is an executer
protein that cleaves different substrates to generate DNA
fragmentation and morphological changes, such as the
appearance of apoptotic bodies. These characteristics were
observed at different times of exposure. By contrast, cas-
pase 8, a protein that self-cleaves as a result of the activa-
tion of the extrinsic pathway, maintained expression when
breast cancer cells were exposed to arantho EO. This
result indicated that the extrinsic pathway was not acti-
vated. Additionally, the EOs of Citrus bergamia (0.005 %)
and Aniba rosaeodora (400 nL/mL) also induce apoptosis
via the activation of caspase 3 and 9 after 1 and 2 h of
treatment for the SH-SY5Y and A431 cell lines, respect-
ively [12]. By contrast, the Bcl-2 family is also a key regu-
lator of apoptosis, and it includes apoptotic (Bax, Bak, and
Bid) and antiapoptotic molecules (Bcl-2 and Bcl-xl) [31].
In our study, the expression of Bax was increased in breast
cancer cells exposed to arantho EO as early as 3 h. These
data were consistent with the expression of proteins in-
volved in the intrinsic pathway, and it was expected that
the expression of Bcl-2 decreased in the treated cancer
cells. Therefore, the results are consistent with other EOs
that downregulate Bcl-2 protein expression in different
cancer cells to induce apoptosis as a relevant strategy to
control cancer development and progression [30]. These
observations suggest that EO is an interesting natural anti-
tumoral candidate for the treatment of cancer. We propose
that EO activates the Bax protein, which permeabilizes the
outer membrane of mitochondria. This generates large
pores that allow the release of cytochrome c and activate
caspase 9 and caspase 3, resulting in cell death.
The cytotoxic activities of natural products, such as EOs,
are mainly attributed to the presence of different bioactive
compounds, including terpenes, terpenoids, alkanes, and
aromatic components [32]. Interestingly, phytochemical
analysis of the D. bicolor EO showed the presence of differ-
ent compounds, particularly hydrocarbons and terpenes.
Table 1 EO composition of arantho leaves
No Compound Retention time (min) KI Abundance (%)
1 α-Pinene 1.8 885 2.60
2 Camphene 2.06 1008 0.91
3 β-Pinene 2.37 1042 1.18
4 β-Phellandrene 2.5 1057 1.03
5 β-Myrcene 2.92 1104 1.05
6 Limonene 3.34 1151 4.49
7 2-Hexenal 3.63 1183 3.04
8 3-Carene 3.97 1211 0.94
9 2-Heptanol acetate 4.29 1230 5.13
10 2-Heptanol 4.35 1233 3.20
11 Acetic acid, octyl ester 6.3 1348 1.28
12 Eucalyptol 6.90 1383 1.10
13 Linalool 7.2 1401 1.53
14 1-(3-Methyl-cyclopent-2-enyl)-cyclohexene 7.38 1410 6.12
15 Acetic acid,1,7.7-trime-bicyclo [2.2.1] 7.51 1417 3.82
hept-2-yl ester
16 Terpineol 7.65 1424 1.04
17 Acetic acid, decyl ester 8.36 1461 2.11
18 β-Terpineol 8.91 1490 8.16
19 1,5-Cyclooctadiene,3-(methyl-2)propenyl 9.45 1518 18.38
20 Germacrene 12.16 1657 3.07
21 Methyl salicylate 13.5 1684 1.07
22 Elemol 16.71 1870 1.07
23 Hedycaryol 19.36 1980 1.05
KI Kovats Retention Index
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This result is consistent with the consensus of the chem-
ical composition of EOs, indicating that the three main
groups of compounds are terpenes and terpenoids, aro-
matics (phenolic) and aliphatics [6]. However, 1-5-cyclooc
tadiene,3-(methyl-2)propenyl and 1-(3-methyl-cyclopent-
2-enyl-cyclohexene, two hydrocarbons that were major
compounds identified in D. bicolor EO, may be respon-
sible for the cytotoxic activity of this EO towards the
MDA-MB-231 breast cancer cells, although nothing is
known of its antitumoral activity. Nevertheless, other con-
stituents of EO may contribute to the cytotoxicity. EOs
isolated from antitumoral plants of the Rutaceae family of
the genus Citrus (C. aurantium, C. limon and C. reticu-
lata) possess a highly different chemical composition
compared to D. bicolor, which may be due to the differ-
ence in their genetic profile and environmental conditions
[10]. Moreover, several of the metabolites identified were
isolated in other studies and demonstrated cytotoxic and
antitumoral activities. One of the three major compounds
identified in D. bicolor EO is α-terpineol, which decreased
both the viability of the MCF-7 breast cancer cell with an
IC50 value of 16.2 μM [33] and the expression of NF-kB
[34]. Other important less abundant compounds in D.
bicolor EO that have been isolated from other medicinal
plants and possess antitumoral effect are limonene, α-
pinene and linalool. α-Pinene is a monoterpene that in-
duces apoptosis in SK-OV3, HO-8910, Bel-7402 [21] and
C32 cancer cells [35]. Linalool had a cytotoxic effect on
melanoma [35], breast cancer cells [36] and hepatocarci-
noma cells [37]. Limonene is a monoterpene representative
of the Rutaceae family. It inhibits the growth of different
cell lines, such as DU-145 prostate [38], carcinoma cells,
with an IC50 of 2.8 mM. However, limonene, linalool and
α-pinene previously tested on MDA-MB-231 breast cancer
cells were not cytotoxic [39]. These investigations indicate
that several metabolites present in arantho EO are cytotoxic
to different cancer cell lines; however, it is difficult to attri-
bute the biological activity to the entire EO or to one
specific compound because the cytostatic effect of an entire
plant on cancer cells is often better than the effect of the
particular biological active compounds [7]. In addition, due
to the lipophilic nature of EO, volatile compounds appear
to accumulate in the cell membrane and increase its
permeability, resulting in the leakage of enzymes and
metabolites that induces cytotoxic and apoptotic effect in
cancer cells [6]; however, is necessary to identify the active
compound responsible for the cell death of these breast
cancer cells.
Conclusion
In conclusion, several assays demonstrated an important
cytotoxic, selective and apoptotic activity of the EO of D.
bicolor against the breast cancer cell line MDA-MB-231,
Additional in vitro and in vivo studies currently under
study will allow us to determine the sensitivity of other
cell lines and the anti-tumoral potential of the essential
oil from arantho (EO).
Additional file
Additional file 1: MTT assays of the different extracts of D. bicolor on
MDA-MB-231 breast cancer cell line. The graphics represent the MTT
assays of the different extracts (aqueous, ethanolic, acetonic and hexanic)
of D. bicolor on breast cancer cells MDA-MB-231. The ethanolic, acetonic
and hexanic extracts demonstrated a cytotoxic effect in a doses and time
dependent manner, obtaining IC50 values of 128.20 ± 2.035, 203.2 ± 2.3
and 450.7 ± 2.657 μg/mL, respectively. However, the aqueous extract
didn’t showed any cytotoxic activity at any concentration or time. The
experiments were performed at least in triplicate and the values are
reported as mean ± SE, *P < 0.05 as compared to control cells (medium
alone). Significance was analyzed using One-way ANOVA followed by
Tukey test. (PDF 270 kb)
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